Bank of America’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-868,700
Closed -$84.8M 7439
2025
Q3
$84.8M Buy
868,700
+314,100
+57% +$32.5M 0.01% 1317
2025
Q2
$59.6M Sell
554,600
-83,300
-13% -$8.43M ﹤0.01% 1547
2025
Q1
$64.4M Sell
637,900
-65,100
-9% -$6.56M 0.01% 1379
2024
Q4
$62.8M Sell
703,000
-152,500
-18% -$13.4M 0.01% 1323
2024
Q3
$71.7M Buy
855,500
+244,600
+40% +$19.3M 0.01% 1289
2024
Q2
$47M Sell
610,900
-159,400
-21% -$11.7M ﹤0.01% 1499
2024
Q1
$52.8M Sell
770,300
-74,300
-9% -$4.78M ﹤0.01% 1449
2023
Q4
$48.8M Buy
844,600
+422,300
+100% +$22.5M ﹤0.01% 1375
2023
Q3
$22.3M Buy
422,300
+132,400
+46% +$6.94M ﹤0.01% 1920
2023
Q2
$15.7M Sell
289,900
-216,600
-43% -$11.3M ﹤0.01% 2268
2023
Q1
$25.3M Buy
506,500
+274,300
+118% +$12.9M ﹤0.01% 1911
2022
Q4
$10.7M Buy
232,200
+52,800
+29% +$2.29M ﹤0.01% 2625
2022
Q3
$6.95M Buy
179,400
+145,300
+426% +$5.83M ﹤0.01% 2998
2022
Q2
$1.27M Sell
34,100
-30,700
-47% -$1.25M ﹤0.01% 4687
2022
Q1
$2.87M Sell
64,800
-30,500
-32% -$1.32M ﹤0.01% 4213
2021
Q4
$4.05M Sell
95,300
-357,900
-79% -$15M ﹤0.01% 3864
2021
Q3
$19.7M Buy
453,200
+293,900
+184% +$13M ﹤0.01% 2192
2021
Q2
$6.81M Buy
159,300
+140,700
+756% +$5.92M ﹤0.01% 3231
2021
Q1
$719K Sell
18,600
-687,300
-97% -$26M ﹤0.01% 5092
2020
Q4
$25.4M Buy
705,900
+705,700
+352,850% +$25.4M ﹤0.01% 1671
2020
Q3
$8K Sell
200
-11,700
-98% -$451K ﹤0.01% 6500
2020
Q2
$418K Sell
11,900
-4,800
-29% -$173K ﹤0.01% 4739
2020
Q1
$545K Sell
16,700
-199,100
-92% -$7.78M ﹤0.01% 4448
2019
Q4
$9.76M Buy
215,800
+190,000
+736% +$7.95M ﹤0.01% 2576
2019
Q3
$1.05M Sell
25,800
-36,500
-59% -$1.55M ﹤0.01% 4511
2019
Q2
$2.68M Buy
62,300
+61,100
+5,092% +$2.35M ﹤0.01% 3795
2019
Q1
$46K Sell
1,200
-301,800
-100% -$11.5M ﹤0.01% 6224
2018
Q4
$10.7M Sell
303,000
-839,500
-73% -$30.4M ﹤0.01% 2234
2018
Q3
$44M Buy
1,142,500
+1,133,200
+12,185% +$39.6M 0.01% 1186
2018
Q2
$304K Sell
9,300
-277,300
-97% -$8.36M ﹤0.01% 5181
2018
Q1
$7.83M Buy
286,600
+277,300
+2,982% +$7.54M ﹤0.01% 2649
2017
Q4
$231K Buy
+9,300
New +$257K ﹤0.01% 5339
2016
Q4
Sell
-50,000
Closed -$1.19M 7042
2016
Q3
$1.19M Buy
+50,000
New +$1.19M ﹤0.01% 4042
2016
Q2
Sell
-143,700
Closed -$2.7M 7125
2016
Q1
$2.7M Buy
143,700
+43,700
+44% +$768K ﹤0.01% 3313
2015
Q4
$1.84M Buy
+100,000
New +$1.79M ﹤0.01% 3871
2015
Q3
Sell
-120,000
Closed -$2.12M 7209
2015
Q2
$2.12M Sell
120,000
-261,200
-69% -$4.67M ﹤0.01% 3402
2015
Q1
$6.77M Buy
381,200
+81,100
+27% +$1.28M ﹤0.01% 2209
2014
Q4
$3.98M Buy
300,100
+251,700
+520% +$3.22M ﹤0.01% 2759
2014
Q3
$571K Buy
48,400
+3,400
+8% +$42.8K ﹤0.01% 4462
2014
Q2
$575K Buy
45,000
+1,900
+4% +$24.7K ﹤0.01% 4477
2014
Q1
$583K Sell
43,100
-17,900
-29% -$235K ﹤0.01% 4448
2013
Q4
$733K Buy
61,000
+6,900
+13% +$81.5K ﹤0.01% 4389
2013
Q3
$636K Sell
54,100
-254,400
-82% -$2.75M ﹤0.01% 4404
2013
Q2
$2.86M Buy
+308,500
New +$2.62M ﹤0.01% 2817

Other funds holding BSX

Bank of America's BSX Position: Q1 2026 in Review

Bank of America reduced its Boston Scientific (BSX) stake by 9.4% in Q1 2026, selling an estimated $189M and leaving 22,756,646 shares worth $1.43B. The position accounts for 0.1% of the portfolio, ranked #187.

Bank of America first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.64B in Q2 2025. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Bank of America held 22,756,646 shares of Boston Scientific worth $1.43B as of Q1 2026.
  • Bank of America sold 2,358,539 Boston Scientific shares in Q1 2026, an estimated $189M.
  • Boston Scientific made up 0.1% of Bank of America's portfolio in Q1 2026, its #187 holding.
  • Bank of America first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Boston Scientific position peaked at $3.64B in Q2 2025.
  • 1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.